Retatrutide 20mg

Retatrutide is a triple glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptor agonist. This advanced peptide works by activating multiple metabolic pathways to support weight management and metabolic health.

The compound enhances insulin secretion in response to glucose, promotes satiety, and increases energy expenditure. It also supports improved glycemic control and may help reduce appetite and food cravings.

Retatrutide represents a next-generation approach to metabolic support, combining the benefits of three receptor pathways in a single peptide. Users may experience improved body composition, enhanced metabolic rate, and better overall metabolic function.

This 20mg formulation is designed for research and personal use applications. Always consult with a healthcare provider before use, and ensure compliance with all local regulations regarding peptide products.